论文部分内容阅读
目的:探究在功能失调性子宫出血的激素治疗中子宫内膜厚度对临床治疗方案选择的影响分析。方法:2014年1月至2015年12月期间,我院妇科接受治疗的功能失调性子宫出血患者126例,根据患者不同激素治疗方案治疗中超声检测显示的子宫内膜厚度结合其临床治疗效果进行综合分析,观察治疗方案选择是否有差异。结果:在126例患者不同的功能失调性治疗方案中显示内膜脱落法治疗的患者中其子宫内膜厚度为0.84mm,而内膜修复法治疗的患者其子宫内膜厚度为0.85mm,无统计学差异(P>0.05),与患者的激素治疗选择方案没有关系,而与患者的年龄与血红蛋白指标相关联。结论:在功能失调性子宫出血患者的激素治疗选择中需要结合其年龄以及血红蛋白指标进行确定,子宫内膜厚度不能起决定性参考作用,也不能作为判定其治疗效果的唯一指标。
OBJECTIVE: To investigate the effect of endometrial thickness on the choice of clinical regimen during steroid therapy of dysfunctional uterine bleeding. Methods: From January 2014 to December 2015, 126 patients with gynecological dysfunctional uterine bleeding underwent gynecological treatment in our hospital. The thickness of endometrium showed by the ultrasound examination of different hormonal treatment regimens in combination with its clinical effect A comprehensive analysis to observe whether the treatment options are different. RESULTS: In 126 different dysfunctional treatment regimens, endometrial thickness was 0.84 mm in patients treated with endometrial ablation, whereas endometrial thickness was 0.85 mm in patients treated with endometrial repair, none Statistical differences (P> 0.05) were not related to the patient’s hormone therapy regimen, but to patient age and hemoglobin status. CONCLUSIONS: The choice of hormonal therapy in patients with dysfunctional uterine bleeding needs to be determined in combination with their age and hemoglobin parameters. Endometrial thickness can not serve as a definitive reference and can not be used as a sole indicator of treatment outcome.